Progesterone in traumatic brain injury: time to move on to phase III trials

There are several candidate neuroprotective agents that have been shown in preclinical testing to improve outcomes following traumatic brain injury (TBI). Xiao and colleagues have performed an in hospital, double blind, randomized, controlled clinical trial utilizing progesterone in the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandromme, Marianne, Melton, Sherry M, Kerby, Jeffrey D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481452/
https://www.ncbi.nlm.nih.gov/pubmed/18522765
http://dx.doi.org/10.1186/cc6899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481452/
https://www.ncbi.nlm.nih.gov/pubmed/18522765
http://dx.doi.org/10.1186/cc6899

Ejemplares similares